FACT (facilitates chromatin transcription) is a protein complex that allows RNAPII to overcome the nucleosome-induced barrier to transcription. While abundant in undifferentiated cells and many cancers, FACT is not abundant or is absent in most tissues. Therefore, we screened for additional proteins that might replace FACT upon differentiation. Here we report the identification of two such proteins, LEDGF and HDGF2, each containing two HMGA-like AThooks and a PWWP methyl-lysine reading domain known to bind to H3K36me2 and H3K36me3. LEDGF and HDGF2 localize with H3K36me2/3 at genomic regions containing active genes, usually adjacent to H3K27me3 domains. In myoblasts, where FACT expression is low, LEDGF and HDGF2 are enriched on most active genes. Upon differentiation to myotubes, LEDGF levels decrease across the genome while HDGF2 levels are maintained. Moreover, HDGF2 is recruited to the majority of myotube up-regulated genes and is required for their proper expression. HDGF2 knockout myoblasts exhibit an accumulation of paused RNAPII proximal to the first nucleosome within the transcribed region of many HDGF2 target genes, indicating a defect in early elongation. We propose that LEDGF and HDGF2 substitute for FACT in differentiated tissues and that their distribution on the genome helps maintain transcriptional programs unique to particular cell types.
Main Text
RNA polymerase II (RNAPII) transcription is regulated at the level of initiation, promoter escape, pause release and elongation (1, 2) . After pause release, RNAPII must overcome a nucleosome-induced barrier to transcription (3, 4) . Two decades ago, we identified FACT (facilitates chromatin transcription) as a protein complex composed of SPT16 and SSRP1 that alleviates this nucleosome-induced barrier to transcription (5, 6) . More recently, we mapped the genomic binding of FACT in stem cells using ChIP-seq with an SPT16 antibody and found that FACT occupancy varies, being associated at high levels with only a subset of active genes (Fig. 1A) . In addition, we and others have found that FACT is only expressed at high levels in some progenitor and transformed cells ( Fig. 1B) (7, 8) . These observations imply the existence of alternative FACT-like chaperones in differentiated cells. We first hypothesized that the BET family proteins (Brd2, Brd3 and Brd4), which also possess FACT-like activity in vitro, might replace FACT at these genes (9, 10) . However, BET proteins predominately localize with acetylated nucleosomes proximal to the transcription start site (TSS) of genes, while a novel chaperone capable of fulfilling the function of FACT should localize in gene bodies (10, 11) .
Exploiting a similar biochemical strategy that first led us to identify FACT, we fractionated HeLa cell nuclear extract and identified a fraction that was depleted of FACT, BET proteins and Nucleolin (RNA Polymerase I-specific FACT-like chaperone), yet able to support transcription through nucleosomes (fig. S1A & S1B) (5, 9, 10, 12) . Following further chromatographic fractionation and mass spectrometry we identified LEDGF long isoform (p75) (also known as PSIP1) (Figs. 1C-D) (13, 14) . Semi-quantitative proteomics and RNA-seq data suggests that this protein as well as its family member, HDGF2, are relatively abundant and expressed in most tissues (not shown), unlike the restricted expression of FACT. LEDGF and HDGF2 each contain a methyl-lysine reading PWWP domain that has been shown to recognize H3K36me2/3, two HMGA-like AT hooks (similar to Nucleolin) and an Integrase Binding Domain (IBD) ( Fig. 1E) (15) (16) (17) (18) (19) . The short isoform of LEDGF (p52) and another PWWP containing protein, HDGF, lack the IBD and the latter contains an HMGB domain instead of HMGA-like AT hooks (20) . LEDGF and HDGF2 have generated considerable interest given their requirement for lentiviral integration, which favors integration into the body of transcribed genes by concurrently binding directly to lentiviral integrase and H3K36me2/3 in the host cell chromatin (16, 21) . Interestingly, retroviruses which favor integration near the TSS of transcribed genes utilize BET proteins in an analogous manner (22, 23) . LEDGF and HDGF2 share another similarity with BET proteins in that they remain bound to mitotic chromosomes suggesting they might contribute to transcriptional memory (24) (25) (26) .
To validate the FACT-like activity of LEDGF and its related proteins, we generated and tested purified recombinant versions of these proteins in an in vitro reconstituted chromatin transcription assay (Fig. 1F) . As depicted, both isoforms of LEDGF (p75 and p52) as well as HDGF2 allow RNAPII to transcribe through nucleosomes in a manner similar to FACT. HDGF which lacks the HMGA-like AT hooks did not substitute for FACT, suggesting that the FACTlike activity of these proteins probably lies within the region that contains the AT hooks ( Fig.  1E) (20) . Increasing amounts of FACT, LEDGF or HDGF2 led to a linear increase in transcription activity such that at least two or more molecules of LEDGF and HDGF2 per nucleosome appeared to be required for efficient transcription in the assay (Figs. 1G-I).
To investigate the functions of LEDGF and HDGF2 in RNAPII transcription in vivo, we first asked whether their binding correlates with regions having RNAPII occupancy and variable levels of FACT initially in 293T cells ( Fig. 2B) . Of note, all three factors; FACT, LEDGF and HDGF2 are highly expressed in 293T cells unlike more differentiated cells ( Fig. 1B & 2A) . Thus, we performed native ChIP-seq using FLAG antibody in 293T cells stably expressing FLAG-LEDGF and FLAG-HDGF2, and compared their occupancy with SPT16, H3K36me2, H3K36me3 and H3K27me3 on RNAPII bound loci (Figs 2C & S2A). We also performed ChIPseq with LEDGF antibody in 293T cells and observed a similar binding pattern to that of FLAG-LEDGF, validating the antibody to be used in later experiments (not shown). After selecting RNAPII bound loci, K-mean clustering segregated the loci into six clusters based on high, medium and low levels of either FACT or LEDGF/HDGF2 respectively ( fig. S2A ). SPT16 most closely correlated with high levels of RNAPII binding in accordance with its high levels in 293T cells ( Fig. 2A) . Although some of the genes having high levels of RNAPII were enriched with all three factors (SPT16, LEDGF and HDGF2), many genes have low levels SPT16 (low FACT) and instead were enriched with LEDGF and HDGF2 ( Fig. 2C and S2A) . These findings suggest that LEDGF and HDGF2 may facilitate transcription of a subset of genes that have low levels of FACT.
Our detailed bioinformatics analysis revealed that SPT16 binding closely correlated with highly expressed housekeeping genes, whereas LEDGF and HDGF2 were more enriched on genes greater in length that exhibit a higher frequency of RNAPII pausing (figs. S2B-D). In contrast to SPT16, we observed a striking correlation between the localization of LEDGF and HDGF2 with H3K36me2 ( Figs. 2C & S2A) , consistent with their ability to bind both H3K36me2 and H3K36me3 through their PWWP domains (15, 18) . For example, similar to that of H3K36me2 domains, ChIP-seq profiles for LEDGF and HDGF2 on an approximately 12 Mb track of chromosome 6 showed that these factors decorate broad domains which include clusters of active genes that are opposed by domains demarked by H3K27me3 (Fig 2C) . At this megabase level of visualization it is apparent that SPT16 binding is variable, not equally enriched on all clusters of actively transcribed genes and when present, is more restricted to only transcribed genes similar to H3K36me3 and RNAPII. A more detailed bioinformatics analysis of these data utilizing Markov modeling reinforces this partitioning at the genomic level ( fig.  S3 ). We also found an unparalleled opposition between H3K27me3 and H3K36me2 across the genome (Fig. 2D) . These modifications and their opposition probably co-evolved together as lower organisms such as S. Cerevisiae have neither Polycomb Repressive Complex 2 (PRC2), the sole enzyme responsible for H3K27 methylation, nor dedicated H3K36 di-methylase enzymes (27) . Interestingly, S. Cerevisiea does not contain a homolog of LEDGF/HDGF2, though Drosophila does, an organism that also has PRC2 and dedicated H3K36 di-methylase enzymes (28, 29) .
We next characterized the histone modifications associated with the FLAG-LEDGF and FLAG-HDGF2 by quantitative ChIP-MS (11) . As shown in Figure 2E , the nucleosomes associated with both LEDGF and HDGF2 were highly enriched in H3K36me2 as compared with whole genome histones (Input). Interestingly, HDGF2 also enriched H3K36me3 suggesting that these proteins have a somewhat different binding preference. The nucleosomes associated with both proteins were depleted of the repressive chromatin associated modifications, H3K27me2 and H3K27me3 (27) . These results are consistent with our ChIP-seq data and provide more direct evidence that these proteins bind H3K36me2 and H3K36me3 in vivo (Fig. 2C ). Though we were not able to reconstitute the dependency on these modifications in vitro using the reconstituted transcription assay with synthetic modification-mimic histones (data not shown), the PWWP domains of LEDGF and HDGF2 were both shown to be required for these proteins to bind chromatin in vivo (26, 30) . This discrepancy is likely due to other domains (i.e., AT-hooks) of the LEDGF and HDGF2 proteins which exhibit DNA and nucleosome binding affinities independent of their PWWP domains and are sufficient to bind unmodified nucleosomes in a defined in vitro assay (15) .
To determine if LEDGF and HDGF2 are recruited to genes upon induction, we performed ChIP-seq in mESCs before and after differentiation to embryoid bodies using knockout-validated LEDGF and HDGF2 antibodies ( fig. S4) . We also performed ChIP-seq for SPT16, RNAPII, H3K27me3, H3K36me2 and H3K36me3. However, in order to quantitatively analyze the ChIP-seq data from these two conditions (ESC vs EB), we performed these and all subsequent experiments with spike-in controls (31) . Interestingly, in mESCs LEDGF is rather dispersed, being found in large domains usually containing some active genes, whereas HDGF2 exhibits a binding pattern similar to SPT16, being more restricted to the bodies of actively transcribed genes ( Figs. 3A-B ). Upon differentiation (ESC to EB), approximately 881 genes showed a 2-fold (or more) increase in RNAPII binding and HDGF2 was recruited to 40% of these genes (Fig. 3C) . The ChIP-seq binding patterns of SPT16 revealed that it was also recruited to 58% of these genes and had a 23% overlap with HDGF2 ( Fig. 3C) . Moreover, the opposite trend holds true, as genes with reduced RNAPII (ESC to EB) usually exhibited a decrease in HDGF2 and SPT16 binding. Representative examples of specific genes showing these phenomena are presented in Figs. 3A and 3B. These results indicate that both HDGF2 and FACT follow RNAPII deposition at a subset of genes during mESCs differentiation.
In order to validate that LEDGF and HDGF2 participate in transcription we utilized CRISPR/Cas9 technology to knockout (KO) LEDGF alone or together with HDGF2 (LEDGF/HDGF2 dKO) in mESCs. We did not observe a large number of genes whose expression (RNA-seq, 2-fold-change cutoff, BH corrected p-value < 0.05) was affected in either KO cell line compared to WT mESCs ( Fig. 3D ), suggesting that there is a redundancy likely due to high levels of FACT or other unknown factors ( Fig. 2A) . Interestingly, when we differentiate these mESCs into EBs, we observed a significant number of genes (1884 genes) affected in the LEDGF/HDGF2 dKO cells ( Fig. 3D) . However, the changes in the LEDGF KO cells were still minimal, implying a redundancy between LEDGF and HDGF2 at this stage of cellular differentiation.
Given that HDGF2 was recruited to approximately 40% of the genes that increase expression during differentiation of ESCs to EBs (Fig 3C) , we next analyzed the effect of the LEDGF/HDGF2 dKO on these upregulated genes. Upon differentiation (ESC to EB), 2308 genes exhibited at least a 2-fold increase in expression in WT cells as measured by RNA-seq ( Fig. 3E ). Of these differentially expressed genes, ~27% failed to fully activate in the LEDGF/HDGF2 dKO cells (Figs. 3E-F). Average ChIP-seq read density profiles showed a correlation between these genes and an increase in HDGF2 binding (ESC to EB) ( Fig. 3G top  left panel) . Conversely, we did not observe this correlation on the genes that were activated to the same extent in dKO cells as in WT cells (Fig. 3G, bottom left panel) . However, such genes did correlate with an increase in SPT16 binding, possibly indicating redundancy (Fig 3G, bottom middle panel). SPT16 binding generally showed an overall increase on most genes that gain expression from ESC to EB, even those genes that failed to properly induce in the dKO cells ( Fig. 3G) . Such redundancy could explain why many of the induction-compromised genes still showed partial activation in the dKO cells ( Fig. 3F) .
To control for the possible redundancy between LEDGF/HDGF2 and FACT, we utilized myoblast (MB) to myotube (MT) cellular differentiation system (32, 33) as protein levels of FACT (SPT16 and SSRP1) and LEDGF decrease while HDGF2 remain constant during differentiation into MT (Fig 4A) . As expected, binding of both LEDGF and HDGF2 on the genome correlated with RNAPII levels as evidenced by average density profiles in MB ( Fig. 4B upper panels & S5A). However, SPT16 was only detected at low levels on a few highly expressed genes in MB. Upon differentiation into MT, SPT16 was not detected on any genes and LEDGF binding decreased globally while HDGF2 remained enriched on actively transcribed loci and accumulated on genes whose expression was induced (Figs. 4B lower panels & S6D).
As these data indicate that a MB to MT differentiation system is ideal for studying the function of HDGF2, we generated a HDGF2 KO in MB ( fig. S6A) . Upon differentiation to MT, 822 genes exhibited a 2-fold (or more) increase in expression in WT cells as measured by RNAseq while ~60% of these genes failed to properly induce in HDGF2 KO cells (Figs. 4C & S6B-D). Importantly, HDGF2 binding increased on these genes upon differentiation of WT cells, but not on genes that exhibited normal induction in the HDGF2 KO cells (Fig. 4D) . In contrast, LEDGF exhibited a decrease in its global binding upon differentiation ( Fig. 4B & 4D ). An example of this phenomenon is observed at the myosin heavy chain (MHC) cluster that contains genes induced during differentiation to MT ( Fig. 4E) . Upon differentiation, HDGF2 levels increase on the induced genes within the cluster whereas LEDGF binding decreased uniformly across the entire cluster. SPT16 binding was undetectable on this cluster in both the MB and MT. The induced expression of these genes was dependent on HDGF2 as their induction was not detected by RNA-seq in HDGF2 KO MT as compared to WT MT (Fig. 4E, bottom tracks) . These data strongly suggest that in myotubes, which contain undetectable levels of FACT and low levels of LEDGF, the binding of HDGF2 to chromatin is required for induction of its target genes.
We observed that most genes being expressed in both the myoblast and myotube were enriched in HDGF2 at both stages. An example of one such highly expressed gene (NES) that is dependent on HDGF2 is shown in Figure 4F . However, RNA-seq analysis revealed many such genes that are not dependent on HDGF2 (figs. S6B-C). Therefore, the low levels of LEDGF in myotubes as well as additional factors that possess FACT-like activity likely exist for continued expression of these genes. One such additional factor may be NDF, which was recently identified in Drosophila embryo extract through a screen for factors that stimulate acetylation of nucleosomes in vitro by the acetyltransferase p300 (34) . Notably, NDF (CG4747) and the fly homolog of LEDGF/HDGF2 (CG7946) were originally identified together by ChIP-MS as proteins that enriched with actively transcribed chromatin containing H3K36me3 (29) .
Similar to 293T cells, we observed an opposition between H3K27me3 with H3K36me2, LEDGF and HDGF2 in MB (Fig 2C-D & Figs. 4E-G) . Interestingly, upon differentiation to MT, a silent gene (C20orf166) in the MB located within an H3K27me3 domain, is induced and concurrently we observed a loss in H3K27me3 with an accumulation of HDGF2 (Fig. 4G) . The expression of this gene was dependent on HDGF2, suggesting an interplay between HDGF2 and H3K27me3 domains during differentiation.
To better understand how HDGF2 affects transcription in cells, we employed PRO-Seq in the WT and HDGF2 KO myoblast cells. PRO-seq precisely maps the level of engaged RNAPII on genes as mature transcripts are washed away during the nuclear isolation process (35) . Metagene profiles of PRO-seq data revealed an increased RNAPII occupancy within the promoter proximal region of many HDGF2 target genes in the HDGF2 KO as compared to WT cells (Fig. 4H) . This data suggests that HDGF2 does not impact initiation, but rather the RNAPII transition to transcript elongation. Strikingly, the increased RNAPII peaks observed on genes in HDGF2 KO cells correlates with the first nucleosome position (Fig. 4I) , indicating that HDGF2 helps relieve the nucleosome-induced block to transcription, consistent with our biochemical data (36) . Notably this RNAPII pausing phenotype was observed in two independent HDGF2 KO myoblast cell lines, both of which could be rescued by stable lentiviral expression of HDGF2, demonstrating that the effect seen is due to HDGF2 elimination ( Fig. 4H-I, right panels and S6E) .
In conclusion, we have identified two factors, LEDGF and HDGF2, as proteins which allow RNAPII to overcome the nucleosome-induced barrier to transcription elongation in differentiated cells that no longer express FACT (Fig 4J) . During cellular differentiation histone modifications reorganize leading to distinct cells types with unique transcriptional profiles. In light of our findings, we propose that these proteins reorganize with histone modifications to maintain chromatin in a transcriptional competent state, hence overriding the requirement for FACT and helping to sustain the unique transcriptional profiles of particular cell types. E. Venn diagram depicting the number of up-regulated genes (2-fold) from ESC to EB in WT cells overlaid with the down-regulated genes in the LEDGF/HDGF2 dKO EBs. Of the 2308 genes normally up-regulated in the WT cells (ESC to EB), 618 were found to be down regulated in the dKO EB cells. The overlap with dKO down regulated genes is significant (p-value = 3.15e-97, hypergeometric test). 
Figure Legends

Chromatin assembly and chromatin transcription assays.
Chromatin assembly and chromatin transcription assays were performed as described in (2, 3) .
Recombinant LEDGF p75, LEDGF p55, HDGF2 and HDGF proteins.
The cDNAs encoding the LEDGF p75, LEDGF p55, HDGF2 and HDGF proteins were cloned into the CBF vector (Addgene) at the SMA-1 site which when expressed makes a N-terminal FLAG Tagged fusion protein. The LEDGF p75, LEDGF p55, HDGF2 and HDGF proteins were produced and purified with the same protocol as used for Brd2, Brd3 and Brd4 described in (2, 3) .
Native FLAG-LEDGF and FLAG-HDGF2 ChIP-seq and ChIP-MS.
Native FLAG-ChIPs for ChIP-seq and ChIP-MS were performed in 293T cells as described in (4) . FLAG-LEDGF and FLAG-HDGF2 stable cell lines were produced using the pQCXIP retroviral vector (Clonetech).
ChIP-seq
ChIP-seq experiments were performed as described before (5) . In brief, nuclei was isolated from cells fixed with 1% Formaldehyde. Next, using a Diagenode Bioruptor, chromatin was fragmented into ~250bp. Chromatin immunoprecipitation was performed with the antibodies listed in below. Chromatin from Drosophila (1:100 ratio to the experimental chromatin) as well as Drosophila specific H2Av antibody was used as spike-in control in each sample. For ChIPseq, libraries were prepared as described in (6) using 1-30 ng of immunoprecipitated DNA.
RNA-seq
Total RNA from ESCs, EBs, 293Ts, MB and MTs was isolated with RNAeasy (Qiagen) and reverse transcribed using Superscript III and random hexamers (Life Technologies) to synthesize the 1st strand. Second strand was synthesized with dUTP to generate strand asymmetry using DNA Pol I (NEB, M0209L) and the E. coli ligase (Enzymatics, L6090L). RNA-seq libraries were constructed using the protocol described in (6) . Mouse ESC culture and differentiation. E14Tga2 (ATCC, CRL-1821) ESCs were grown in standard medium supplemented with LIF, 1 μM MEK1/2 inhibitor (PD0325901, Stemgent) and 3 μM GSK3 inhibitor (CHIR99021, Stemgent). For embryoid body differentiation, 600K mESCs were plated in suspension plates with medium containing DMEM (Life Technologies), 20% FBS, 1% NEAA, 1% Pen/Strep, 2 mM L-Glutamine, 100 mM Ascorbic acid (Sigma). After 5 days, EB colonies were collected for downstream applications.
Antibodies
Myoblast cell culture and differentiation to Myotubes.
Human myoblasts were obtained from as a generous gift from the Blau lab (Stanford University). Cells are seeded on gelatinized plates and grown in Ham's F-10 media (Gibco/Thermo Fisher) supplemented with 15% fetal bovine serum (Atlanta Biologicals), 1mM sodium pyruvate (Sigma), 100ug/ml penicillin/streptomycin (Gibco/Thermo Fisher), 2.5ng/ml basic human fibroblast growth factor (Promega), 1X GlutaMax (Thermo Fisher) and 1uM Dexamethasone. Once 90% confluent the myoblasts are differentiated to myotubes by changing the media to DMEM (Gibco/Thermo Fisher) supplemented with 2% Horse Serum (Hyclone) and 100ug/ml penicillin/streptomycin (Gibco/Thermo Fisher). Differentiation proceeds for 6 days and the efficiency can be monitored with microscopy as myotubes are easily visually detected.
293T cell culture.
293T cells were cultured as described in (4) .
CRISPR genome editing.
gRNAs were designed using CRISPR design tool in https://benchling.com. All gRNAs below were cloned in pSpCas9(BB)-2A-GFP (Addgene plasmid #48138) or to a lentiviral vector pLKO.1-puro U6 sgRNA (Addgene plasmid #50920). The gRNAs were transfected into mESCs using Lipofectamine 2000 (Life Technologies) or infected into Myoblasts together with lentiCas9-eGFP (Addgene plasmid #63592). Single clones from GFP positive and/or puromycin resistant cells were genotyped and confirmed by sequencing.
gRNAs
Following gRNAs are used to knockout human HDGF2: hsHDGF2-gRNA-KO1: GCCACACGCCTTCAAGCCCG hsHDGF2-gRNA-KO2: CACCGGCCCCATCTCCCGCG Following gRNAs are used to knockout mouse HDGF2: msHDGF2-gRNA-KO1: TACCATCCAGTTACTTAGGG msHDGF2-gRNA-KO2: GCTCACCTGGAACTGGCCTA Following gRNAs are used to knockout mouse LEDGF: msLEDGF-gRNA-KO1: TTTTCAATGGAGCTGATCTG msLEDGF-gRNA-KO2: GGTCTCATTGGAACATCCTA
HDGF2 rescue myoblast cell lines
Clonal HDGF2 KO myoblast cell lines were rescued with the lentivirus pLV-EF1a-IRES-Blast that had the HDGF2 cDNA inserted within the multiple cloning sites (BamH1 and EcoR1). Following infection, cells were selected for Blasticidin resistance. The HDGF2 cDNA was modified to make it resistant to the CRISPr gRNAs used to knockout HDGF2.
Tissue expression
The levels of expression FACT subunits (SSRP1 and SPT16) shown in Figure 1B were obtained with the Expression Atlas (https://www.ebi.ac.uk/gxa/home) and ordered by hierarchical clustering.
